Gradient Denervation Technologies jobs and careers

About Gradient Denervation Technologies

Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Biotechnology Medical Device

Founded: 2019
Employees: 1 to 10
Total funding: $14M

Leadership

The top of Gradient Denervation Technologies's org chart, with how many people report into each leader.

Martin Grasse

CEO

7 reports

David Amaoua

Chief Technology Officer

4 reports

Charlotte Cavé

COO

1 report

Jobs at Gradient Denervation Technologies

No open positions right now. Explore more companies on TheJobsMap.